Switch to:
Myriad Genetics Inc (NAS:MYGN)
EV/EBITDA
10.47 (As of Today)

EV/EBITDA ratio is calculated as enterprise value divided by its EBITDA. As of today, Myriad Genetics Inc's enterprise value is $2,030.8 Mil. Myriad Genetics Inc's earnings before depreciation and amortization for the trailing twelve months (TTM) ended in Mar. 2016 was $193.9 Mil. Therefore, Myriad Genetics Inc's EV/EBITDA ratio for today is 10.47.

MYGN' s EV/EBITDA Range Over the Past 10 Years
Min: -161.3   Max: 38.5
Current: 10.49

-161.3
38.5

During the past 13 years, the highest EV/EBITDA Ratio of Myriad Genetics Inc was 38.50. The lowest was -161.30. And the median was 9.40.

MYGN's EV/EBITDA is ranked higher than
69% of the 105 Companies
in the Global Diagnostics & Research industry.

( Industry Median: 14.15 vs. MYGN: 10.49 )

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

As of today, Myriad Genetics Inc's stock price is $31.97. Myriad Genetics Inc's earnings per share for the trailing twelve months (TTM) ended in Mar. 2016 was $1.48. Therefore, Myriad Genetics Inc's P/E Ratio for today is 21.60.

The "classic" EV/EBITDA ratio is much better in capturing debt and net cash than the P/E Ratio.


Definition

Myriad Genetics Inc's EV/EBITDA for today is calculated as:

EV/EBITDA=Enterprise Value (Today)/Earnings Before Depreciation and Amortization (TTM)
=2030.794/193.9
=10.47

Myriad Genetics Inc's current Enterprise Value is $2,030.8 Mil.
Myriad Genetics Inc's Earnings Before Depreciation and Amortization for the trailing twelve months (TTM) ended in Mar. 2016 was 42.8 (Jun. 2015 ) + 50.1 (Sep. 2015 ) + 51.9 (Dec. 2015 ) + 49.1 (Mar. 2016 ) = $193.9 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

Myriad Genetics Inc's P/E Ratio for today is calculated as:

P/E Ratio=Share Price (Today)/Earnings Per Share (TTM)
=31.97/1.48
=21.60

Myriad Genetics Inc's share price for today is $31.97.
Myriad Genetics Inc's Earnings Per Share for the trailing twelve months (TTM) ended in Mar. 2016 was 0.26 (Jun. 2015 ) + 0.37 (Sep. 2015 ) + 0.41 (Dec. 2015 ) + 0.44 (Mar. 2016 ) = $1.48.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Study has found that the companies with the lowest EV/EBITDA outperforms companies measured as cheap by other ratios such as P/E Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Related Terms

Enterprise Value, Earnings Before Depreciation and Amortization, P/E Ratio


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Myriad Genetics Inc Annual Data

Jun06Jun07Jun08Jun09Jun10Jun11Jun12Jun13Jun14Jun15
ev2ebitda -18.79-76.2622.9224.657.059.778.577.579.2813.81

Myriad Genetics Inc Quarterly Data

Dec13Mar14Jun14Sep14Dec14Mar15Jun15Sep15Dec15Mar16
ev2ebitda 4.017.859.2811.3111.8513.3913.8113.7915.3612.47
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK